drugset / Trial / NCT00346775

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

NCT00346775

Phase 3 Completed 97 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindTreatment

Summary

The Protocol section needs to be updated using the following text "The main goal of the study was to validate the Preference Module of the EARNS-Q and to test the reliability using Treatment Satisfaction Questionnaire for Medicines (TSQM), a validated questionnaire for determining satisfaction among different treatment. The EARNS-Q is divided into 2 modules, an Experience Module and a Preference Module. The Experience Module includes 28 items, fourteen attribute rating items followed by fourteen importance weighing questions. The Preference Module includes the same items along with preference questions related to each item as well as a global preference question.

Timeline

Start
2006-05-01
Primary completion
2006-06-29
Completion
2006-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Flunisolide Small molecule
Subject beclomethasone dipropionate Other / unclassified